Pour en savoir plus…<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"La soci\u00e9t\u00e9 de biotechnologie, AbolerIS Pharma, d\u00e9veloppe des immunoth\u00e9rapies innovantes. Elle a conclu un accord avec Ouest Valorisation, au nom de l’INSERM, du CNRS, du CHU de Nantes et de l’Universit\u00e9 de Nantes, pour licencier des anticorps monoclonaux anti-CD45RC. Pour en savoir plus…<\/p>\n","protected":false},"author":35,"featured_media":22797,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,568],"tags":[],"class_list":["post-22811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-successstories-en"],"acf":[],"yoast_head":"\n
AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Thomas Labeyrie\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/\"},\"author\":{\"name\":\"Thomas Labeyrie\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3\"},\"headline\":\"AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation\",\"datePublished\":\"2020-12-07T16:57:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/\"},\"wordCount\":59,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png\",\"articleSection\":[\"News\",\"Success Stories\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/\",\"url\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/\",\"name\":\"AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png\",\"datePublished\":\"2020-12-07T16:57:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png\",\"width\":877,\"height\":607},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3\",\"name\":\"Thomas Labeyrie\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/thomas-labeyrieouest-valorisation-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/","twitter_misc":{"Written by":"Thomas Labeyrie"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/"},"author":{"name":"Thomas Labeyrie","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3"},"headline":"AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation","datePublished":"2020-12-07T16:57:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/"},"wordCount":59,"image":{"@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png","articleSection":["News","Success Stories"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/","url":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/","name":"AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png","datePublished":"2020-12-07T16:57:00+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/12\/Photo-actu-.png","width":877,"height":607},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/aboleris-pharma-signe-une-licence-mondiale-exclusive-avec-ouest-valorisation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"AbolerIS Pharma signe une licence mondiale exclusive avec Ouest Valorisation"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/520a6aec7cf33f5c7ecc4f3936b478f3","name":"Thomas Labeyrie","url":"https:\/\/www.satt.fr\/en\/author\/thomas-labeyrieouest-valorisation-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/22811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=22811"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/22811\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/22797"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=22811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=22811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=22811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}